AIIMS Pharmacist Vacancy 2025

AIIMS Pharmacist Vacancy 2025 The Common Recruitment Examination (CRE)-2024 is for the recruitment on various posts at participating AIIMS and Central Government Institutes/bodies where each institute is autonomous body/subordinate office and independent Organization under Government of India. AIIMS, New Delhi is only conducting examination for all participating Institutes based on detail provided by the respective … Read more

Lenacapavir: A Game-Changer in HIV Treatment

Lenacapavir: A Game-Changer in HIV Treatment In the ongoing battle against HIV, a new weapon has emerged: Lenacapavir. This innovative medication, belonging to the class of capsid inhibitors, is revolutionizing the way HIV is treated, particularly for those with multidrug-resistant strains. Understanding Lenacapavir Lenacapavir is a medication used to treat HIV-1 infection in adults. It … Read more

Exploring a Career in Pharmacovigilance: A Guide for Pharmacy Students

Exploring a Career in Pharmacovigilance: A Guide for Pharmacy Students Pharmacovigilance is a critical field within the healthcare industry, focusing on the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. For pharmacy students, pursuing a career in pharmacovigilance offers a unique opportunity to contribute to patient safety and public health … Read more

Indian Pharma Companies Embrace AI and Machine Learning for Drug Discovery and Development

Indian Pharma Companies Embrace AI and Machine Learning for Drug Discovery and Development Introduction The Indian pharmaceutical industry, a global powerhouse, is undergoing a significant transformation driven by technological advancements. Artificial intelligence (AI) and machine learning (ML) are emerging as key catalysts, revolutionizing drug discovery, development, and manufacturing processes. Indian pharma companies are increasingly investing … Read more

NPPA Announces Increase in Drug Prices: What You Need to Know

NPPA Announces Increase in Drug Prices: What You Need to Know In a recent development that has garnered significant attention, the National Pharmaceutical Pricing Authority (NPPA) has announced an increase in the ceiling prices of several essential drugs. This decision, effective from October 8, 2024, is a strategic move aimed at addressing the dynamic challenges in the pharmaceutical sector while ensuring that life saving medications remain both accessible and available to the public. Understanding the National Pharmaceutical Pricing Authority (NPPA) The National Pharmaceutical Pricing Authority (NPPA) was established in 1997 under the Ministry of Chemicals and Fertilizers, Government of India. Its primary role is to ensure the availability and affordability of medicines by regulating drug prices in the country. The NPPA monitors the prices of scheduled drugs under the Drug Prices Control Order (DPCO) and ensures that manufacturers comply with the prescribed ceiling prices. This regulatory body plays a crucial role in protecting consumer interests and promoting rational use of medicines. What is a Ceiling Price? A ceiling price is the maximum price that can be charged for a product or service, set by the government to protect consumers from excessive pricing. In the context of pharmaceuticals, the NPPA sets the ceiling prices for essential medicines listed under the DPCO. These prices are determined based on various factors, including the cost of production, market demand, and economic conditions. The primary objective is to make essential medicines affordable while ensuring that manufacturers can sustain their operations and continue to supply these drugs. Recent Changes in Drug Prices The NPPA has recently approved a 50% increase in the ceiling prices of eleven scheduled formulations of eight drugs. These drugs are crucial for treating a range of medical conditions, including asthma, glaucoma, thalassemia, tuberculosis, and mental health disorders. The price hike is primarily attributed to the rising costs of Active Pharmaceutical Ingredients (APIs), production expenses, and fluctuations in exchange rates. The NPPA has emphasized that this adjustment is necessary to ensure the continued availability of these essential drugs in the market. … Read more

Top 10 Pharmaceutical Industries in India: Pioneers of Innovation and Healthcare

Top 10 Pharmaceutical Industries in India: Pioneers of Innovation and Healthcare India’s pharmaceutical industry stands as a global powerhouse, renowned for its significant contributions to healthcare and medicine. With a rich history of innovation, these companies have not only catered to the domestic market but have also made a substantial impact on the global stage. … Read more

Nobel Prize 2024: Celebrating the Groundbreaking Discovery of microRNA

Nobel Prize 2024: Celebrating the Groundbreaking Discovery of microRNA The 2024 Nobel Prize in Physiology or Medicine has been awarded to two pioneering scientists, Victor Ambros and Gary Ruvkun, for their revolutionary discovery of microRNA. This breakthrough has unveiled a new dimension in gene regulation, fundamentally altering our understanding of cellular processes and opening new … Read more

Dr. Reddy’s Strategic Acquisition of Haleon’s Nicotine Replacement Therapy Portfolio: A Game-Changer in the Global NRT Market

Dr. Reddy’s Strategic Acquisition of Haleon’s Nicotine Replacement Therapy Portfolio: A Game-Changer in the Global NRT Market In a significant move that underscores its commitment to expanding its global footprint, Dr. Reddy’s Laboratories has successfully acquired Haleon’s global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for a substantial sum of GBP 458 million. This … Read more

Over 50 Popular Drugs Fail Quality Tests: A Wake-Up Call for the Pharmaceutical Industry

Over 50 Popular Drugs Fail Quality Tests: A Wake-Up Call for the Pharmaceutical Industry In a recent development that has sent shockwaves through the pharmaceutical industry, the Central Drug Standards Control Organisation (CDSCO) has flagged more than 50 widely-used medications as “Not of Standard Quality” (NSQ). This revelation has raised significant concerns about drug safety … Read more

Strides Pharma Receives USFDA Approval for Theophylline Extended-Release Tablets

Strides Pharma Receives USFDA Approval for Theophylline Extended-Release Tablets Strides Pharma Science Ltd, a prominent Indian pharmaceutical company, has achieved a significant milestone by securing approval from the United States Food and Drug Administration (USFDA) for its generic version of Theophylline extended-release tablets. This approval marks a crucial step in providing cost-effective treatment options for respiratory conditions such … Read more